article thumbnail

Biobanks VS Biorepositories: The Difference

Cloudbyz

The short answer is that all Biobanks are Biorepositories, but not all Biorepositories are Biobanks. Realistically speaking, the terms “Biobank” and “Biorepository” are used pretty interchangeably. The differences we can point out when someone asks: What is the difference between Biobanks and Biorepositories?

article thumbnail

AstraZeneca analysed rare variant contribution to human disease

Drug Discovery Today

AstraZeneca scientists, based in Cambridge UK, have analysed over 18,000 phenotypes in combination with whole exome sequencing data from nearly 300,000 UK Biobank research participants.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Biorepositories as a Guiding Resource for Research & Drug Discovery

XTalks

Biobanks are used for the coordination of high-yield patient sample collection. Moreover, biobanks are no longer passive biorepositories for accrual of samples and serve a more utilitarian function in identifying and coordinating specific research cohorts for longitudinal and prospective studies. Biobanking Models.

article thumbnail

Can genetic data be a magic bullet for drug R&D?

pharmaphorum

As part of the US government’s Cancer Moonshot initiative, a Cancer Moonshot Biobank was launched that asked participants to donate biospecimens and associated health information to aid research. Scientists are able to study the aggregated, de-identified genetics of these individuals.

article thumbnail

Why early participant engagement is now a top priority in genetic disease research

pharmaphorum

In 2016, scientists behind a study called the Resilience Project analysed genetic data from 589,000+ people and found 13 adults who carried genetic variants that should have resulted in serious – even deadly – childhood disease, but who were apparently healthy. First, start co-development with participants early on in the process.

article thumbnail

New Research Reveals How Air Pollution May Trigger Lung Cancer

XTalks

Now, scientists have found a mechanism that may help explain how pollutants in the air can turn cells cancerous. The scientists say that their research provides evidence to limit air pollution and also opportunities for molecular targeted cancer prevention. The researchers propose that particulate matter 2.5 Furthermore, inhaling PM 2.5

article thumbnail

A new dawn of the genomic age: five areas set to be transformed in 2023

pharmaphorum

A 2022 study from the Royal College of Physicians and British Pharmacological Society demonstrated the potential of pharmacogenomics, with scientists identifying the genetic cause behind an individual’s drug response for over forty medicines. But for the promised benefits to come to fruition, researchers must be armed with quality data.

Genomics 129